ClinEco plans on leaning heavily on Rob’s diverse expertise in the management of online marketplaces and startup growth as we work to deliver the best possible experiences of all clinical research stakeholders.
NEEDHAM, Mass. (PRWEB)
May 09, 2023
ClinEco, the world’s first online community for clinical trial organizations to explore, engage and exchange capabilities with an ecosystem of partners, announced today that it has named Rob Ristagno, President of International Operations at Vistage Worldwide, to its advisory board. In his role, Ristagno will counsel ClinEco leadership as they plan their next chapter of growth for the clinical trial partnership platform.
“We are thrilled to have Rob as one of our advisors. Rob’s experience is different from the rest of our team, as his background is not in clinical research but rather in helping companies grow. This makes him a great complement to the rest of our advisory board and a valuable member of our team,” said Micah Lieberman, Co-Founder and VP of Community and Business Development at ClinEco. “We plan on leaning heavily on Rob’s diverse expertise in the management of online marketplaces and startup growth as we work to deliver the best possible experiences for all our clinical research stakeholders.”
In Ristagno’s current role with Vistage Worldwide, he is focused on building the company’s footprint globally, particularly in Europe, the Middle East and Africa (EMEA) as well as the Latin American and Asia Pacific regions. His previous experience includes building and growing a tech-enabled consultancy, Sterling Woods, where he and his team created over a half billion dollars of enterprise value for small and medium sized businesses. Ristagno’s background also includes time at McKinsey & Company, America’s Test Kitchen and Homesite Insurance in growth-focused executive roles as well as positions at global brands Visa, Pepsi and Comcast. He is a published author, keynote speaker and serves on the board of DRG Holdings. Rob holds an MBA from Harvard Business School and a BA in economics from Dartmouth College and has taught at both Harvard and Boston College.
About ClinEco
ClinEco unites sponsors, CROs, service providers and sites on the world’s first B2B clinical trial marketplace, empowering all to expand clinical partnerships. Through creating a platform where all clinical research stakeholders can explore, engage, and exchange capabilities with an ecosystem of partners, ClinEco accelerates the process of vendor selection, leading to faster, more efficient clinical trials. ClinEco is a Cambridge Healthtech Institute Company. The team responsible for ClinEco is also the team behind the Summit for Clinical Ops Executives (SCOPE).
About CHI
Cambridge Healthtech Institute (CHI) believes bringing together a unique and diverse constellation of innovators, scientists, and life science professionals can hold the key to developing tomorrow’s cures and diagnostics. We are a life science network for leading researchers and business experts from top pharmaceutical, biotech, and academic organizations.
Share article on social media or email: